GW Pharmaceuticals may soon see its epilepsy drug, Epidiolex, approved by the Food & Drug Administration to be a prescription drug.

The drug is made from a component of cannabis that doesn’t give the user the “high,” and is intended for children with severe epilepsy.

Many wonder if the FDA backs the drug, what would it mean for marijuana products that do not have FDA approval.

An attorney in Colorado, who also worked on the pharmaceutical legislation for the drug, told the Associated Press, “The future of the industry is showing itself here.

There’s going to be the pharmaceutical lane, the nutraceutical lane [food as medicine], the adult-use lane. This shows how that’s all coming together.”

FDA advisers unanimously recommended the agency approve the drug back in April and will make a decision by the end of the month.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Teenagers Using Marijuana “Damage their Brains for Life” According to Study
03 October 2018
Los Angeles Wont Be One of the First Cities to Sell Legal Pot Next Week
29 December 2017
Michigan Just Said OK To Important Marijuana Legalization Step
19 May 2017